| ACORN/GSK LPT112515 |
| Breast - Advanced/Metastatic First Line |
| Lapatinib + Trastuzumab vs. Trastuzumab as Continued HER2 Suppression After Completion of 1st or 2nd Line Trastuzumab + Chemo |
| ACORN/GSK LPT112515 |
| Breast - Advanced/Metastatic First Line |
| Lapatinib + Trastuzumab vs. Trastuzumab as Continued HER2 Suppression After Completion of 1st or 2nd Line Trastuzumab + Chemo |